Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia

This is the first report we are aware of documenting a beneficial effect of oxytocin on cognition in schizophrenia. Though from a small sample (n = 15), these data both offset past concerns about oxytocin's amnestic effects, and may auger another potential benefit in addition to the already-demonstrated salutary effects on other components of the illness.